TVM Life Science Ventures VI GmbH & Co KG Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for TVM Life Science Ventures VI GmbH & Co KG.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of TVM Life Science Ventures VI GmbH & Co KG. TVM Life Science Ventures VI GmbH & Co KG is Director in Acer Therapeutics Inc. ($OPXA) and Director in CONCERT PHARMACEUTICALS, INC. ($CNCE) and 10% Owner in PROTEON THERAPEUTICS INC ($PRTO).
Latest Insider Trading Transactions of TVM Life Science Ventures VI GmbH & Co KG
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ACER, CNCE, TARA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12 2018 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 12.00 | 250,000 | 3,000,000 | 1,422,709 | 1.2 M to 1.4 M (+21.32 %) |
| Jan 12 2018 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 12.00 | 21,271 | 255,252 | 248,756 | 227.5 K to 248.8 K (+9.35 %) |
| Jan 12 2018 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 12.00 | 62,062 | 744,744 | 725,844 | 663.8 K to 725.8 K (+9.35 %) |
| Sep 27 2017 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | J | 0.00 | 1,172,709 | 0 | 1,172,709 | 0 to 1.2 M |
| Sep 27 2017 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | J | 0.00 | 227,485 | 0 | 227,485 | 0 to 227.5 K |
| Sep 27 2017 | OPXA | Acer Therapeutics ... | TVM Life Science Ventures VI G ... | Director | Buy | J | 0.00 | 663,782 | 0 | 663,782 | 0 to 663.8 K |
| Jun 26 2017 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | P | 0.99 | 128 | 127 | 500 | |
| Jun 26 2017 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | P | 0.99 | 372 | 370 | 500 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | J | 0.00 | 451,276 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | J | 0.00 | 1,316,683 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | X | 4.60 | 39,932 | 183,779 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | X | 4.60 | 116,511 | 536,219 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 1,277,663 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 3,727,823 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 799,043 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 2,331,391 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 835,121 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 2,436,618 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 717,260 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 2,092,735 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 1,531,518 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Option Exercise | C | 0.00 | 4,468,482 | 0 | 0 | |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | X | 4.60 | 39,932 | 183,779 | 1,943,059 | 1.9 M to 1.9 M (+2.10 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | X | 4.60 | 116,511 | 536,219 | 1,903,127 | 1.8 M to 1.9 M (+6.52 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | C | 0.00 | 379,462 | 0 | 1,786,616 | 1.4 M to 1.8 M (+26.97 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | C | 0.00 | 1,107,154 | 0 | 1,407,154 | 300 K to 1.4 M (+369.05 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | P | 10.00 | 76,590 | 765,900 | 300,000 | 223.4 K to 300 K (+34.28 %) |
| Oct 30 2014 | PRTO | PROTEON THERAPEUTI ... | TVM Life Science Ventures VI G ... | 10% Owner | Buy | P | 10.00 | 223,410 | 2,234,100 | 223,410 | 0 to 223.4 K |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 288,407 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 1,084,813 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 561,550 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 841,493 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 3,165,187 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Option Exercise | C | 0.00 | 1,638,450 | 0 | 0 | |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 14.00 | 22,713 | 317,982 | 378,703 | 356 K to 378.7 K (+6.38 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | P | 14.00 | 66,287 | 928,018 | 1,104,969 | 1 M to 1.1 M (+6.38 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 51,045 | 0 | 355,990 | 304.9 K to 356 K (+16.74 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 192,003 | 0 | 304,945 | 112.9 K to 304.9 K (+170.00 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 99,389 | 0 | 112,942 | 13.6 K to 112.9 K (+733.34 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 148,936 | 0 | 1,038,682 | 889.7 K to 1 M (+16.74 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 560,211 | 0 | 889,746 | 329.5 K to 889.7 K (+170.00 %) |
| Feb 20 2014 | CNCE | CONCERT PHARMACEUT ... | TVM Life Science Ventures VI G ... | Director | Buy | C | 0.00 | 289,991 | 0 | 329,535 | 39.5 K to 329.5 K (+733.34 %) |
Page: 1